Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors

Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors

US Patent 10300059 · Granted May 28, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and magnetic imaging devices to inventory human brain cortical function2025
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositi2025
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositi2025
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositi2025
Methods and magnetic imaging devices to inventory human brain cortical function2023
Methods and magnetic imaging devices to inventory human brain cortical function2023
Methods and magnetic imaging devices to inventory human brain cortical function2023
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositi2023
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositi2023
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositi2023
Methods and magnetic imaging devices to inventory human brain cortical function2022
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositi2021